Effects of circulating myostatin on skeletal muscle mass in patients undergoing peritoneal dialysis
Not Applicable
- Conditions
- Endstage kidney disease
- Registration Number
- JPRN-UMIN000019085
- Lead Sponsor
- Department of Integrated Therapy for Chronic Kidney Disease, Graduate School of Medical Sciences, Kyushu University
- Brief Summary
Multivariable analyses showed that serum myostatin level was positively associated with skeletal muscle mass and use of vitamin D receptor activators. By contrast, serum myostatin level was negatively associated with higher age and female gender in patients undergoing peritoneal dialysis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who do not have frozen serum
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum myostatin level
- Secondary Outcome Measures
Name Time Method Skeletal muscle mass